Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways
12. Oktober 2021 08:00 ET
|
Scipher Medicine Corporation
ATLANTA and WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the integration of PrismRA®, a diagnostic...
UPDATE - Scipher Medicine Welcomes Sam Davis as General Counsel
24. September 2021 12:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
Scipher Medicine Welcomes Sam Davis as General Counsel
24. September 2021 09:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer
22. September 2021 10:50 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of John...
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer of its Diagnostics Business
20. September 2021 11:11 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announces the addition of Chip Parkinson...
Ventegra Partners with Scipher Medicine For Patient-Centric Approach To Improve Outcomes and Lower Costs for Rheumatoid Arthritis Care
16. September 2021 08:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with Ventegra,...
Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class
24. Juni 2021 08:00 ET
|
Scipher Medicine Corporation
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection WALTHAM, Mass., June 24, 2021 ...
Scipher Medicine Announces $82 Million Financing
24. März 2021 08:00 ET
|
Scipher Medicine Corporation
-aMoon and Northpond Ventures led the round.-Additional investors include Echo Health Ventures, Khosla Ventures and Alumni Ventures.-Financing will support commercialization of precision medicine...
Mariann Byerwalter joins Scipher Medicine’s Board of Advisors
01. Dezember 2020 08:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has appointed Mariann Byerwalter to its Board of...